Atrial Fibrillation Burden: Impact on Stroke Risk and Beyond.
Ahmed AlTurki, Vidal Essebag
https://pubmed.ncbi.nlm.nih.gov/38674182/Actively Recruiting
Led by University Hospital of Patras · Updated on 2026-03-13
244
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are evaluating left bundle branch pacing LBBP compared with conventional right ventricular RV pacing in patients who have preserved left ventricular ejection fraction LVEF above 50% and require frequent ventricular pacing due to atrioventricular AV conduction disorders. This randomized controlled trial aims to study the total time of atrial high-rate episodes AHREs, which are episodes of fast heart rhythm detected by implanted devices and linked to risks like atrial fibrillation and thromboembolic events. The study focuses on whether LBBP can reduce AHRE burden better than RV pacing by providing more natural heart activation. Participants are randomly assigned to receive either a dual-chamber pacemaker with the ventricular lead placed in the right ventricular septum or with the lead placed at the left bundle branch area. The devices are commercially available and programmed for physiological pacing. Researchers will monitor pacing percentages and configurations during follow-up visits. The study period lasts 24 months from pacemaker implantation or randomization, during which various episode durations and clinical events will be recorded. During the study, participants will undergo device diagnostics to detect AHREs, with a portion of episodes reviewed to confirm their atrial origin and exclude false readings. Safety events, hospitalizations, changes in heart function, biomarkers, and quality of life will be assessed at multiple time points up to two years. The primary outcome is the total cumulative AHRE time for episodes lasting more than six minutes. This comprehensive monitoring and follow-up will help determine the impact of pacing type on atrial arrhythmias and related health outcomes.
CONDITIONS
Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF
G
GEORGIOS LEVENTOPOULOS
P
Periklis Davlouros
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital of Patras
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants receive implantation of a dual-chamber pacemaker with the ventricular lead placed either at the left bundle branch area or in the right ventricular septum depending on randomization.
1 implantation visit (in-person)
Duration - 24 months
Participants are monitored for atrial high-rate episodes and pacing performance through device diagnostics over the study period.
Regular follow-up visits at baseline, 3, 6, 12, 18, and 24 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Ahmed AlTurki, Vidal Essebag
https://pubmed.ncbi.nlm.nih.gov/38674182/Giuseppe Boriani, Enrico Tartaglia, Paola Trapanese...
https://pubmed.ncbi.nlm.nih.gov/39980773/Gelu Simu, Radu Rosu, Gabriel Cismaru...
https://pubmed.ncbi.nlm.nih.gov/33496721/Victoria Jansson, Lennart Bergfeldt, Jonas Schwieler...
https://pubmed.ncbi.nlm.nih.gov/34036145/Nina Becher, Andreas Metzner, Tobias Toennis...
https://pubmed.ncbi.nlm.nih.gov/38953776/Gregg F Rosner, James A Reiffel, Kathleen Hickey
https://pubmed.ncbi.nlm.nih.gov/28496712/University Hospital of Patras
Lead Sponsor